G007-LK is primarily utilized in cancer research due to its potential as an anti-tumor agent. It functions by targeting specific signaling pathways involved in cell proliferation and survival, making it a promising candidate for inhibiting the growth of certain cancer cells. Researchers are particularly interested in its ability to enhance the efficacy of existing chemotherapy treatments by sensitizing resistant cancer cells. Additionally, G007-LK is being explored for its role in reducing tumor metastasis, offering potential for improving outcomes in advanced-stage cancers. Its application extends to preclinical studies, where it aids in understanding the molecular mechanisms of cancer progression and identifying novel therapeutic strategies.